Delivery Order SPE2DR25D2014-SPE2DR26FA1C7
Award Date 12/31/25
Potential Completion Date 1/2/26
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp received a competitive delivery order award from the Defense Logistics Agency (DLA) valued at $8,291.76 for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product for immunological conditions. The contract is unclassified as a set-aside and carries a firm fixed-price structure with an ultimate completion date of September 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters, where...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order contract award from the Defense Logistics Agency (DLA) on December 18, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls. This firm fixed-price delivery order, valued at $2,387.94, is set to be completed by December 19, 2025, and will be fulfilled at the contractor's Conshohocken facility. The contract represents a non-set-aside, competitively awarded...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,612.06 by the Defense Logistics Agency on December 16, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This is a firm fixed price, competitively awarded contract with an ultimate completion date of December 17, 2025. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- AmerisourceBergen Drug Corp was awarded a delivery order for HUMIRA Pen 40mg/4ml (2 units) with a ceiling value of $39,878.72 by the Defense Logistics Agency on December 15, 2025. This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of December 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 22, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mls, a biologic medication used to treat inflammatory conditions. This is a firm fixed-price delivery order with a ceiling value of $4,531.80 and an ultimate completion date of May 23, 2025. The contract is non-competitive with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $9,916.38 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to a location in Conshohocken, Pennsylvania. The contract has a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and does...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $2,770.74 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,855.43 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the pharmaceutical product HUMIRA PEN 40 MG/0.8 MLS and has a completion date of February 8, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to the Department of Defense through various DLA contracts....
- AmerisourceBergen Drug Corp was awarded a $30,792.85 delivery order contract for HUMIRA Pen 40mg/4mL (2-pack units) under a firm fixed-price arrangement with an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside delivery order is issued by the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceutical and medical products to support the Department of Defense's healthcare operations, including military treatment facilities and the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 19, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This non-set-aside, competitively awarded contract has a ceiling value of $3,815.69 and is structured as a firm fixed price delivery order with an ultimate completion date of December 22, 2025. The award...